scPharmaceuticals Inc. (SCPH) Dividend History

scPharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing innovative, FDA-approved products that address unmet medical needs. The company's primary focus is on hospital and specialty care markets, providing therapies that improve patient outcomes and healthcare efficiency.

25 Burlington Mall Road, Suite 203, Burlington, MA, 01803
Phone: 617-517-0730
Website:

Dividend History

scPharmaceuticals Inc. currently does not pay dividends

Company News

  • scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

    scPharmaceuticals Inc. announced a proposed underwritten public offering of shares of its common stock or pre-funded warrants to purchase shares. The offering is subject to market and other conditions.

    GlobeNewswire Inc.
  • scPharmaceuticals to Present at the Jefferies Global Healthcare Conference

    BURLINGTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, will present at the Jefferies Global Healthcare Conference on Wednesday, June 5 at 5:00PM ET. Mr. Tucker will also be meeting with investors that day.

    GlobeNewswire Inc.
  • ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Lags Revenue Estimates

    scPharmaceuticals (SCPH) delivered earnings and revenue surprises of 20% and 6.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: ALVO
  • scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

    Generated 1Q 2024 net FUROSCIX® revenue of $6.1 million, despite an estimated 10% impact to doses filled resulting from the Change Healthcare cyberattack

    GlobeNewswire Inc.
  • scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

    BURLINGTON, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, will present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference, which will be held at the NASDAQ World Headquarters in New York on Monday, May 20, at 11:00AM ET. Mr. Tucker will also be meeting with investors during the event.

    GlobeNewswire Inc.
Dividend data last updated 06/08/2025 01:44:16 UTC